|
Brain Waves
|
E01.370.376.300.150 |
|
|
Glycogen Phosphorylase, Liver Form
|
D08.811.913.400.450.460.400.186.124 |
|
|
Muscular Atrophy
|
C23.888.592.608.612 |
|
|
Thiamethoxam
|
D03.383.533.820 |
|
|
Logical Observation Identifiers Names and Codes
|
D039703 |
[A vocabulary database of universal identifiers for laboratory and clinical test results. Its purpose is to facilitate the exchange and pooling of results for clinical care, outcomes management, and research. It is produced by the Regenstrief Institute. (LOINC and RELMA [Internet]. Indianapolis: The Regenstrief Institute; c1995-2001 [cited 2002 Apr 2]. Available from http://www.regenstrief.org/loinc)
] |
|
Felodipine
|
D015736 |
[A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
] |
|
Cytochalasin D
|
D03.633.100.473.231.450 |
|
|
Tardive Dyskinesia
|
C23.888.592.350.275.500 |
|
|
Dyskinesia, Drug-Induced
|
C23.888.592.350.275 |
|
|
Nisoldipine
|
D015737 |
[A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
] |
|
Stress Disorders, Traumatic, Acute
|
D040701 |
[A class of traumatic stress disorders that is characterized by the significant dissociative states seen immediately after overwhelming trauma. By definition it cannot last longer than 1 month, if it persists, a diagnosis of post-traumatic stress disorder (STRESS DISORDERS, POST-TRAUMATIC) is more appropriate.
] |
|
Nobelium
|
D01.268.271.100.575 |
|
|
Mifepristone
|
D015735 |
[A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
] |
|
Famotidine
|
D015738 |
[A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
] |
|
Nocodazole
|
D015739 |
[Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.
] |
|
Maneb
|
D02.241.081.251.869.265.441 |
|
|
Tetanus Toxin
|
D23.946.123.893 |
|
|
Imagination
|
F02.463.188.634 |
|
|
Selenomonas
|
B03.440.425.410.800.877 |
|
|
Tetrahydrofolates
|
D03.633.100.733.631.400.800 |
|
